Susana Perez-Gutthann

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Filter by Publication Topic

Search Results

Agomelatine post-authorization safety studies program: Comprehensive results

A validation exercise: Identifying hospitalizations for heart failure among patients with COPD in the CPRD

Hospitalization for heart failure among patients using aclidinium bromide and other COPD medications: A post-authorisation safety study in the CPRD

Agomelatine drug utilisation study in selected European countries: A multinational, observational study to assess effectiveness of risk-minimisation measures

Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources

Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom

Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators

Risk of acute liver injury in Agomelatine and other antidepressant users in four European countries: A cohort and nested case-control study using automated health data sources

GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)

Proportions of cancer cases in primary care, hospital, and cancer registry data among patients treated for overactive bladder

Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project

Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom

Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany

Value of free-text comments for validating cancer cases using primary-care data in the United Kingdom

To pile or not to pile: How to define episodes of use of COPD medications in the CPRD

The missing puff: Results of multiple imputation of PPFEV1 in CPRD

Validity of hospital ICD‐10‐GM codes to identify acute liver injury

Time between laboratory tests and acute liver and kidney injury diagnosis codes in CPRD: Are we doing it right?

Characterization of patients with ulcerative colitis in a postauthorization safety study of golimumab based in the Spanish ENEIDA registry

Tobacco Cessation Treatment Utilization by Kentucky Medicaid Recipients Before and After Medicaid Expansion and Mandated Tobacco Treatment Coverage: 2013-2015